STEELE GLENN JR MD PHD sold PTCT
September 30, 2026 · Form 4 insider transaction
STEELE GLENN JR MD PHD sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 per share, a transaction worth $781.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,000
Price
$65.16
Total value
$781.9K
InsiderSTEELE GLENN JR MD PHD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after22,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 9, 2026